A Great New Option For Multiple Myeloma Patients: Daratumumab Now Available As a Quick Shot, Replacing Long Infusions

Published May 7, 2020

NOW
PLAYING
Ovarian Cancer - New PARP Inhibitor Combination Drug Approval
NOW
PLAYING
PARP Inhibitors For Ovarian Cancer Treatment During COVID-19
NOW
PLAYING
PARP Inhibitor Niraparib Now FDA Approved For Front-Line Ovarian Cancer Treatment
NOW
PLAYING
New Hope For Later Stage Prostate Cancer Patients: The PARP Inhibitor Olaparib Approved By The FDA
NOW
PLAYING
PARP inhibitors and Ovarian Cancer
NOW
PLAYING
Innovative New Drug Approved For Multiple Myeloma Is Being Tested For COVID-19 Treatment
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.